SynthesisMedicine2016

The Efficacy and Safety of Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors for Advanced Melanoma: A Meta-Analysis of Clinical Trials Following the PRISMA Guidelines.

Xiuwen Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.